|

Alzheimer's Disease Clinical Trials in Oregon

12 recruiting studies across 1 city

Browse by City

Portland
12 trials

All Trials in Oregon

Phase
Trial Phase Dist.
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesPhase 3<1 mi
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseasePhase 3<1 mi
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's DiseasePhase 3<1 mi
Trial-Ready Cohort-Down Syndrome (TRC-DS)—<1 mi
OCT Angiography and NRAI in Dementia—<1 mi
Safety and Target Engagement of Centella Asiatica in Cognitive ImpairmentPhase 1<1 mi
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseasePhase 2<1 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 3<1 mi
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseasePhase 2<1 mi
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease DementiaPhase 2/3<1 mi
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)Phase 2<1 mi
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisPhase 27 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.